Multi-country oncology trial share vs Cell and gene therapy venture capital and public funding deal count
Multi-country oncology trial share and Cell and gene therapy venture capital and public funding deal count worldwide, compared over time.
Change the pair
Compare different indicators
The series
Over time
Global, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.
Multi-country oncology trial share
Unit: % · 2 observations
Cell and gene therapy venture capital and public funding deal count
Unit: count · 3 observations
Provenance
Where these numbers come from
Multi-country oncology trial share
Share of oncology trial starts that were multi-country studies.
2 observations in Global · source organisations: IQVIA
Cell and gene therapy venture capital and public funding deal count
Number of venture capital and public funding transactions for cell and gene therapies in a given year.
3 observations in Global · source organisations: IQVIA
Data published under CC BY 4.0. Series A as JSON · Series B as JSON
Keep exploring